Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic
germline genetic variant (hereditary cancer syndrome—HCS). These individuals are …
germline genetic variant (hereditary cancer syndrome—HCS). These individuals are …
(B) On (e)-cohistones and the epigenetic alterations at the root of bone cancer
P Salomoni, AM Flanagan, L Cottone - Cell Death & Differentiation, 2023 - nature.com
Identification of mutations in histones in a number of human neoplasms and developmental
syndromes represents the most compelling evidence to date for a causal role of epigenetic …
syndromes represents the most compelling evidence to date for a causal role of epigenetic …
Spatial gene-expression profiling unveils immuno-oncogenic programs of NF1-associated peripheral nerve sheath tumor progression
DK Mitchell, B Burgess, EE White, AE Smith… - Clinical Cancer …, 2024 - AACR
Purpose: Plexiform neurofibromas (PNF) are benign peripheral nerve sheath tumors (PNST)
associated with neurofibromatosis type 1 (NF1). Despite similar histologic appearance …
associated with neurofibromatosis type 1 (NF1). Despite similar histologic appearance …
[HTML][HTML] Rhabdomyosarcoma arising in inflammatory rhabdomyoblastic tumor: a genetically distinctive subtype of rhabdomyosarcoma
Abstract “Inflammatory rhabdomyoblastic tumor”(IRMT) is a recently coined name for a
distinctive soft tissue neoplasm characterized by slow growth, a dense histiocytic infiltrate …
distinctive soft tissue neoplasm characterized by slow growth, a dense histiocytic infiltrate …
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials
RT Sundby, SD Rhodes, E Komlodi-Pasztor… - Clinical …, 2024 - journals.sagepub.com
Introduction Neurofibromatosis 1 and schwannomatosis are characterized by potential
lifelong morbidity and life-threatening complications. To date, however, diagnostic and …
lifelong morbidity and life-threatening complications. To date, however, diagnostic and …
The spectrum and significance of secondary (co‐occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis
JK Dermawan, BP Rubin - The Journal of Pathology, 2023 - Wiley Online Library
Bone and soft tissue tumors are generally classified into complex karyotype sarcomas
versus those with recurrent genetic alterations, often in the form of gene fusions. In this …
versus those with recurrent genetic alterations, often in the form of gene fusions. In this …
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
AT Larsson, H Bhatia, A Calizo, K Pollard… - Neuro …, 2023 - academic.oup.com
Background Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft tissue
sarcomas that often develop in patients with neurofibromatosis type 1 (NF1). To address the …
sarcomas that often develop in patients with neurofibromatosis type 1 (NF1). To address the …
Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems
L Zhang, J Li - Clinical Epigenetics, 2023 - Springer
Background Detecting organ and tissue damage is essential for early diagnosis, treatment
decisions, and monitoring disease progression. Methylation-based assays offer a promising …
decisions, and monitoring disease progression. Methylation-based assays offer a promising …
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors
Introduction Malignant peripheral nerve sheath tumors (MPNST) pose a significant
therapeutic challenge due to high recurrence rates after surgical resection and a largely …
therapeutic challenge due to high recurrence rates after surgical resection and a largely …
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities
E Creus‐Bachiller, J Fernández‐Rodríguez… - Molecular …, 2024 - Wiley Online Library
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft‐tissue sarcomas
with a poor survival rate, presenting either sporadically or in the context of neurofibromatosis …
with a poor survival rate, presenting either sporadically or in the context of neurofibromatosis …